Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |